Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Serena, Barachini"'
Autor:
Eleonora Pardini, Federico Cucchiara, Sara Palumbo, Giulia Tarrini, Alessia Di Vita, Fabio Coppedè, Vanessa Nicolì, Melania Guida, Michelangelo Maestri, Roberta Ricciardi, Vittorio Aprile, Marcello C. Ambrogi, Serena Barachini, Marco Lucchi, Iacopo Petrini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThymic epithelial tumors are rare malignant neoplasms that are frequently associated with paraneoplastic syndromes, especially myasthenia gravis. GTF2I is an oncogene mutated in a subgroup of thymomas that is reputed to drive their growth.
Externí odkaz:
https://doaj.org/article/1317aeb6d08d463381873c513bc9a53d
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Autophagy is an evolutionarily conserved mechanism of cell adaptation to metabolic and environmental stress. It mediates the disposal of protein aggregates and dysfunctional organelles, although non-conventional features have recently emerged to broa
Externí odkaz:
https://doaj.org/article/3ebdfda9aa6548f4875619417a500e53
Autor:
Mariangela Morelli, Francesca Lessi, Serena Barachini, Romano Liotti, Nicola Montemurro, Paolo Perrini, Orazio Santo Santonocito, Carlo Gambacciani, Matija Snuderl, Francesco Pieri, Filippo Aquila, Azzurra Farnesi, Antonio Giuseppe Naccarato, Paolo Viacava, Francesco Cardarelli, Gianmarco Ferri, Paul Mulholland, Diego Ottaviani, Fabiola Paiar, Gaetano Liberti, Francesco Pasqualetti, Michele Menicagli, Paolo Aretini, Giovanni Signore, Sara Franceschi, Chiara Maria Mazzanti
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundGlioblastoma (GB) is the most severe form of brain cancer, with a 12-15 month median survival. Surgical resection, temozolomide (TMZ) treatment, and radiotherapy remain the primary therapeutic options for GB, and no new therapies have been
Externí odkaz:
https://doaj.org/article/a0c643cddb5e4ccf92ca9ca6b88b0ff3
Autor:
Serena Barachini, Letizia Biso, Shivakumar Kolachalam, Iacopo Petrini, Roberto Maggio, Marco Scarselli, Biancamaria Longoni
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1426 (2023)
Pancreatic islet transplantation is a therapeutic option for achieving physiologic regulation of plasma glucose in Type 1 diabetic patients. At the same time, mesenchymal stem cells (MSCs) have demonstrated their potential in controlling graft reject
Externí odkaz:
https://doaj.org/article/d0ea75f46179483ea4f1eb94601b0ec8
Autor:
Serena Barachini, Marina Montali, Francesca M. Panvini, Vittoria Carnicelli, Gian Luca Gatti, Nicola Piolanti, Enrico Bonicoli, Michelangelo Scaglione, Gabriele Buda, Paolo D. Parchi
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Mesangiogenic progenitor cells (MPCs) have been isolated from human bone marrow (BM) mononuclear cells. They attracted particular attention for the ability to differentiate into exponentially growing mesenchymal stromal cells while retaining endothel
Externí odkaz:
https://doaj.org/article/cc530688b5b740358e5c384efcf0d1c5
Autor:
Francesca M. Panvini, Simone Pacini, Marina Montali, Serena Barachini, Stefano Mazzoni, Riccardo Morganti, Eugenio M. Ciancia, Vittoria Carnicelli, Mario Petrini
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Hematopoiesis is hosted, supported and regulated by a special bone marrow (BM) microenvironment known as “niche.” BM niches have been classified based on micro-anatomic distance from the bone surface into “endosteal” and “central” niches.
Externí odkaz:
https://doaj.org/article/0f9dbc5f22c542d88d0ba5e0ba58b7f7
Autor:
Marina Montali, Francesca M. Panvini, Serena Barachini, Francesca Ronca, Vittoria Carnicelli, Stefano Mazzoni, Iacopo Petrini, Simone Pacini
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-16 (2017)
Abstract Background Mesangiogenic progenitor cells (MPCs) have shown the ability to differentiate in-vitro toward mesenchymal stromal cells (MSCs) as well as angiogenic potential. MPCs have so far been described in detail as progenitors of the mesode
Externí odkaz:
https://doaj.org/article/c6a269e110884a74ac9bc726663c567a
Autor:
Sara Galimberti, Susanna Grassi, Claudia Baratè, Francesca Guerrini, Elena Ciabatti, Francesca Perutelli, Federica Ricci, Giada Del Genio, Marina Montali, Serena Barachini, Cecilia Giuliani, Maria Immacolata Ferreri, Angelo Valetto, Elisabetta Abruzzese, Chiara Ippolito, Alessandra Iurlo, Monica Bocchia, Anna Sicuranza, Bruno Martino, Lorenzo Iovino, Gabriele Buda, Serena Salehzadeh, Mario Petrini, Antonello Di Paolo, Letizia Mattii
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
The Polycomb gene BMI1 expression exerts a negative predictive impact on several hematological malignancies, such as acute and chronic myeloid leukemia (CML), myelofibrosis, and follicular lymphoma. As already demonstrated in CML, BMI1 is responsible
Externí odkaz:
https://doaj.org/article/2bc841b0944a485f95437b0b3a5c2f75
Autor:
Martina Ruglioni, Simone Civita, Tiziano Salvadori, Sofia Cristiani, Vittoria Carnicelli, Serena Barachini, Iacopo Petrini, Irene Nepita, Marco Castello, Alberto Diaspro, Paolo Bianchini, Barbara Storti, Ranieri Bizzarri, Stefano Fogli, Romano Danesi
Programmed death ligand 1 (PD-L1) plays a key role in several human tumors, and it has recently become a crucial target for cancer therapy. Yet, its subtle regulatory roles beside the well characterized immunosuppression in PD-1/PD-L1 immune checkpoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ddd6eb499877b7129afeb67e35751fa
https://doi.org/10.1101/2022.08.09.503318
https://doi.org/10.1101/2022.08.09.503318
Autor:
Iacopo Petrini, Martina Sollini, Francesco Bartoli, Serena Barachini, Marina Montali, Eleonora Pardini, Irene Sofia Burzi, Paola Anna Erba
Publikováno v:
Cancers, 14(11):2592. MDPI AG
Cancers; Volume 14; Issue 11; Pages: 2592
Cancers; Volume 14; Issue 11; Pages: 2592
Simple Summary The extra-domain B fibronectin (ED-B FN) is highly expressed in thymic epithelial tumors (TETs), as demonstrated by in vivo targeting using 131I-labeled L19 small immunoprotein (131I-L19-SIP) and immunohistochemistry with a predominant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3578c78f4eff7538680205a70b323fbd
https://hdl.handle.net/11370/e00d7697-7c49-437a-af66-206edd0f1b32
https://hdl.handle.net/11370/e00d7697-7c49-437a-af66-206edd0f1b32